News

Archexin is a potent inhibitor of Akt protein kinase in the treatment of cancer. The drug is being developed to treat solid tumors and has US FDA Orphan

According to the prescribing information, the patients, who are designated as poor metabolizers, represent nearly 2% of whites, 4% of blacks, and 14% of Chinese. The percentage of

Income from operations was RMB28.6m, a decrease of 66.6% from the fourth quarter of 2008. Net income attributable to shareholders was RMB34.8m, a decrease of 50.5%. For the

Under the terms of the agreement, Sigma-Aldrich has the rights to manufacture and sell the RAFT agents worldwide for all research and development applications. The RAFT agents are

Under the plan, Oximeplus, a Teijin group company and home healthcare equipment provider based in Andalusia, Spain, has been renamed Esteve Teijin Espana (ETE) to better leverage the

The new racking system offers a better use of space, efficient processing and a hygienic containment for parts belonging to machinery used in the production of sensitive products

Inecalcitol is an orally active agonist targeting the vitamin D receptor. The therapeutic rationale behind its development is to add its cytostatic potential to the established efficacy of

The ELISA format of the AppyScore Test is currently in clinical trials for clearance by the FDA and is designed to aid in the evaluation of patients suspected

Comprising almost a third of the whole continent, West Africa is a region with a population of approximately 250 million. Imports of finished products account for over 60%